Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors

Neuroscience

Volumn 90, Issue 4, 1999, Pages 1371-1376

  Storer, R J ^a   Goadsby, P J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Cat; Excitatory amino acids; Headache; Migraine; Pain

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; DIZOCILPINE MALEATE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CAT; CLUSTER HEADACHE; CONTROLLED STUDY; CRANIOTOMY; LAMINECTOMY; MIGRAINE; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINAL CORD DORSAL HORN; STEREOTAXIC SURGERY; SUPERIOR SAGITTAL SINUS;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CATS; CRANIAL SINUSES; DIZOCILPINE MALEATE; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; NEURONS; NOCICEPTORS; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION; TRIGEMINAL NUCLEI;

EID: 0032955976     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00536-3     Document Type: Article

References (54)

1. Bleakman D., Ballyk B. A., Schoepp D. D., Palmer A. J., Bath C. P., Sharpe E. F., Woolley M. L., Bufton H. R., Kamboj R. K., Tarnawa I., Lodge D. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology. 35:1996;1689-1702.
2. Bouassira D., Bars D. L., Villanueva L. Heterotopic activation of A delta and C fibres triggers inhibition of trigeminal and spinal convergent neurones in the rat. J. Physiol. 389:1987;301-317.
3. Boucher Y., Pollin B., Azerad J. Microinfusions of excitatory amino acid antagonists into the trigeminal sensory complex antagonise the jaw opening reflex in freely moving rats. Brain Res. 614:1993;155-163.
4. Chizh B. A., Cumberbatch M. J., Headley P. M. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord. Br. J. Pharmac. 112:1994;843-846.
5. Clements J. R., Magnusson K. R., Hautman J., Beitz A. J. Rat tooth pulp projections to spinal trigeminal subnucleus caudalis are glutamate-like immunoreactive. J. comp. Neurol. 309:1991;281-288.
6. Corsi M., Fina P., Trist D. G. Co-agonism in drug-receptor interaction: illustrated by the NMDA receptors. Trends pharmac. Sci. 17:1996;220-222.
7. Cumberbatch M. J., Hill R. G., Hargreaves R. J. Rizatriptan has central antinociceptive effects against durally evoked responses. Eur. J. Pharmac. 328:1997;37-40.
8. Dickenson A. H. Neurophysiology of opioid poorly responsive pain. Cancer Surv. 21:1994;5-16.
9. Engberg I., Tarnawa I., Durand J., Ouardouz M. An analysis of synaptic transmission to motoneurones in the cat spinal cord using a new selective receptor blocker. Acta physiol. scand. 148:1993;97-100.
10. Fanciullacci M., Alessandri M., Figini M., Geppetti P., Michelacci S. Increases in plasma calcitonin gene-related peptide from extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain. 60:1995;119-123.
11. Feindel W., Penfield W., McNaughton F. The tentorial nerves and localisation of intracranial pain in man. Neurology. 10:1960;555-563.
12. Fletcher E. J., Lodge D. New developments in the molecular pharmacology of α-amino-3-hydroxy-5-methly-4-isoxazole propionate and kainate receptors. Pharmac. Ther. 70:1996;65-89.
13. Gallai V., Sarchielli P., Floridi A., Franceschini M., Codini M., Trequattrini A., Palumbo R. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia. 15:1995;384-390.
14. Goadsby P. J. Bench to bedside: what have we learnt recently about headache? Curr. Opin. Neurol. 10:1997;215-220.
15. Goadsby P. J., Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Brain. 117:1994;427-434.
16. Goadsby P. J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28:1990;183-187.
17. Goadsby P. J., Hoskin K. L. The distribution of trigeminovascular afferents in the non-human primate brain Macaca nemestrina: a c-fos immunocytochemical study. J. Anat. 190:1997;367-375.
18. Goadsby P. J., Hoskin K. L. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)-1-D receptor agonist zolmitriptan (311C90): are brain stem sites a therapeutic target in migraine? Pain. 67:1996;355-359.
19. Goadsby P. J., Knight Y. E. Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. Cephalalgia. 17:1997;153-158.
20. 1B/1D) receptors. Br. J. Pharmac. 122:1997;918-922.
21. Goadsby P. J. and Silberstein S. D. (1997) Headache. Butterworth-Heinemann, New York.
22. Goadsby P. J., Zagami A. S. Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat. Brain. 114:1991;1001-1011.
23. Greene-Tallaksen S. J., Young A. B., Penney J. B., Beitz A. J. Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci. Lett. 141:1993;79-83.
24. 2+ in trigeminal neurons. J. Neurosci. 14:1994;4561-4570.
25. 1b binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states. J. Pharmac. exp. Ther. 243:1987;989-1001.
26. Hill R. G., Salt T. E. An iontophoretic study of the responses of rat caudal trigeminal nucleus neurones to non-noxious mechanical sensory stimuli. J. Physiol. 327:1982;65-78.
27. Honore T., Davies S. N., Drejer J., Fletche E. J., Jacobsen P., Lodge D., Nielsen F. E. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science. 241:1988;701-703.
28. Hoskin K. L., Kaube H., Goadsby P. J. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine: a c-Fos and electrophysiology study. Brain. 119:1996;249-256.
29. Hoskin K. L., Kaube H., Goadsby P. J. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain. 119:1996;1419-1428.
30. Katakura N., Chandler S. H. Iontophoretic analysis of pharmacological mechanisms responsible for initiation and modulation of trigeminal motoneuronal discharge evoked by intra-oral afferent stimulation. Brain Res. 549:1991;66-77.
31. Kaube H., Keay K., Hoskin K. L., Bandler R., Goadsby P. J. Expression of c-fos-like immunoreactivity in the trigeminal nucleus caudalis and high cervical cord following stimulation of the sagittal sinus in the cat. Brain Res. 629:1993;95-102.
32. Lambert G. A., Goadsby P. J., Zagami A. S., Duckworth J. W. Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat. Brain Res. 453:1988;143-149.
33. Lodge D., Bond A., O'Neill M. J., Hicks C. A., Jones M. G. Stereoselective effects of 2,3-benzodiazepines in vivo: electrophysiological and neuroprotection studies. Neuropharmacology. 35:1996;1681-1688.
34. Magnusson K. R., Larson A. A., Madl J. E., Altschuler R. A., Beitz A. J. Co-localization of fixative-modified glutamate and glutaminase in neurons of the spinal trigeminal nucleus of the rat: an immunohistochemical and immunoradiochemical analysis. J. comp. Neurol. 247:1986;477-490.
35. Matsumoto G., Hisamitsu T., de Groat W. C. Non-NMDA glutamatergic excitatory transmission in the descending limb of the spinobulbospinal micturition reflex pathway of the rat. Brain Res. 693:1995;246-250.
36. 1D receptors. Br. J. Pharmac. 123:1998;45-50.
37. McNaughton F. L. (1966) The innervation of the intracranial blood vessels and the dural sinuses. In The Circulation of the Brain and Spinal Cord (eds Cobb S., Frantz A. M., Penfield W. and Riley H. A.), pp. 178-200. Hafner, New York.
38. 3H]sumatriptan binding in cat brain stem and spinal cord. Eur. J. Pharmac. 280:1995;175-178.
39. Nicolodi M., Sicuteri F. Relief of migraine attack with N-methyl-D-aspartic acid receptor antagonist ketamine: a double blind comparison with placebo - theoretic implications. Cephalalgia. 16:1996;372.
40. Ouardouz M., Durand J. Involvement of AMPA receptors in trigeminal post-synaptic potentials recorded in rat abducens motoneurons in vivo. Eur. J. Neurosci. 6:1994;1662-1668.
41. 3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5HT1D and 5HT1F receptors. Eur. J. Pharmac. 295:1996;271-274.
42. Penfield W. A contribution to the mechanism of intracranial pain. Proc. Ass. Res. nerv. ment. Dis. 15:1934;399-415.
43. Pierrefiche O., Foutz A. S., Champagnat J., Denavit Saubie M. NMDA and non-NMDA receptors may play distinct roles in timing mechanisms and transmission in the feline respiratory network. J. Physiol., Lond. 474:1994;509-523.
44. Ray B. S., Wolff H. G. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch. Surg. 41:1940;813-856.
45. Salt T. E., Hill R. G. Differentiation of excitatory amino acid receptors in the rat caudal trigeminal nucleus: a microiontophoretic study. Neuropharmacology. 21:1982;385-390.
46. Seeburg P. H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16:1993;359-365.
47. Shepheard S. L., Williamson D. J., Williams J., Hill R. G., Hargreaves R. J. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in the dura mater and c-fos mRNA expression in the trigeminal nucleus caudalis of rats. Neuropharmacology. 34:1995;255-261.
48. Shukla V. K., Lemaire S. Non-opioid effects of dynorphins: possible role of the NMDA receptor. Trends pharmac. Sci. 15:1994;420-424.
49. Siegel S. (1956) Non-parametric Statistics for the Behavioural Sciences. McGraw-Hill, Kogakusha, Tokyo.
50. 1B/1D agonists inhibits trigeminal cell firing in the cat. Brain. 120:1997;2171-2177.
51. 3H]Sumatriptan labels both 5-HT1D and 5HT-1F receptor bindings sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiedeberg's Arch. Pharmac. 352:1995;263-275.
52. Wolff H. G. (1963) Headache and Other Head Pain. Oxford University Press, New York.
53. Xue D., Huang Z. G., Barnes K., Lesiuk H. J., Smith K. E., Buchan A. M. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J. cerebr. Blood Flow Metab. 14:1994;251-261.
54. Zagami A. S., Goadsby P. J., Edvinsson L. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides. 16:1990;69-75.